Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06554366 · ClinicalTrials.gov registry record · NA
Bacterial Load Reduction by GentleWave and EdgePro Irrigation Systems in Mandibular Necrotic Molars
A NA study of Pulp Necroses, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06554366 is a NA study of Pulp Necroses that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06554366, a NA study of Pulp Necroses, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the efficacy of GentleWave versus EdgePro irrigation in the disinfection of infected root canals of human permanent teeth with necrotic pulp.
Conditions Studied
Interventions
- DEVICE GentleWave
- DEVICE EdgePro laser irrigation
- DEVICE Irrisafe passive ultrasonic irrigation
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-30 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06554366
The ClinicalTrials.gov registry entry for NCT06554366 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulp Necroses appearing as the primary indexed condition, and to 3 interventions - of which GentleWave is the first listed.
NCT06554366 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06554366 about?
NCT06554366 is a clinical study titled "Bacterial Load Reduction by GentleWave and EdgePro Irrigation Systems in Mandibular Necrotic Molars". The purpose of this study is to compare the efficacy of GentleWave versus EdgePro irrigation in the disinfection of infected root canals of human permanent teeth with necrotic pulp.
What is the current status of trial NCT06554366?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-30. Estimated completion is 2026-04-30.
What conditions does trial NCT06554366 study?
This clinical trial studies the following conditions: Pulp Necroses.
What interventions are being tested in trial NCT06554366?
The interventions under investigation include: GentleWave (DEVICE), EdgePro laser irrigation (DEVICE), Irrisafe passive ultrasonic irrigation (DEVICE).
Who is sponsoring clinical trial NCT06554366?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06554366 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.